HuagongsheHuagongshe Chemistry Print Report · For research reference only
[4-(1,3,4-oxadiazol-2-yl)phenyl]boronic Acid → Isobutyl 2-(4-(1,3,4-oxadiazol-2-yl)phenyl)pyridin-3-ylsulfonyl(3-methoxy-5-methylpyrazin-2-yl)carbamate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | [4-(1,3,4-oxadiazol-2-yl)phenyl]boronic Acid | HCID 10219751 | — |
| Reactant | Isobutyl (2-chloropyridin-3-yl)sulfonyl(3-methoxy-5-methylpyrazin-2-yl)carbamate | HCID 11015197 | — |
| Product | Isobutyl 2-(4-(1,3,4-oxadiazol-2-yl)phenyl)pyridin-3-ylsulfonyl(3-methoxy-5-methylpyrazin-2-yl)carbamate | HCID 11489350 | — |
Reaction Steps
In this aspect of the invention [4-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid is coupled with N-(isobutoxycarbonyl)-2-chloro-N-(3-methoxy-5-methylpyrazin -2-yl)pyridine-3-sulphonamide to form N-(isobutoxycarbonyl) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07626020B2 |
| Source dataset | uspto-grants-2009_12 |
| ORD ID | ord-46439bcbf3524748a0f669183ce863b6 |
| Source note | uspto-grants-2009_12 |